Vijay Raghavan

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers SpA is a company based in Milan, Italy.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.

Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy.

AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA.

EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.

The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution.

Idea Entity Corp. provides information technology software solutions. It provides software development, collaboration and engineering services. The company was founded by Venu Yerra in January 2006 and is headquartered in Bellevue, WA.

Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

Newronika SRL manufactures medical and electro-medical equipment and appliances. It offers new adaptive deep brain stimulation systems for movement disorders (DBS); methods and devices for transcranial direct current stimulation (tDCS) represent the non-invasive neuromodulation activity. The company was founded by Priori Alberto and Lorenzo Rossi and is headquartered in Milan, Italy.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy.

Bio4Dreams SpA (B4D) is a incubator firm. The firm was founded by Pietro Conti, Laura Iris Ferro, Elisabetta Borello and Cusi Daniele in 2017 and is headquartered in Bresso, Italy.

Part of Jazz Pharmaceuticals Plc, Jazz Healthcare Italy Srl develops medicines for people with serious diseases. The company is based in Villa Guardia, Italy.

Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy.

Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands.

Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada.

Braindtech SpA engages in providing early diagnosis of brain diseases via liquid biopsy, based on miRNA patterns in microglial microvesicles. The company is headquartered in Bresso, Italy.

Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY.

Angels For Women (A4W) is an angel investment firm was founded by Anna Amati, Paola Bonomo, Antonella Chiricosta, Barbara Cominelli, Laura Donnini, Isabella Falautano, Cinzia Farisè, Laura Iris Ferro, Ester Furlan, Antonella Grassigli, Federica Lolli, Valentina Montanari, Marco Fabio Nannini, Paola Perini, Barbara Poggiali, Cristina Pozzi, Francesca Reich, Laura Rovizzi, Elena Shneiwer, Annamaria Tartaglia, Carlotta Ventura, Elena Vitale in 2018. The firm is headquartered in Milan, Italy.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Kither Biotech Srl is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on the treatment of chronic inflammatory diseases. The company was founded by Emilio Hirsch, Marco Kevin Malisani, and Alberto Bardelli and is headquartered in Turin, Italy.

Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA.

VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation.